New heart pump trial offers hope for End-Stage heart failure patients
NCT ID NCT05353816
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial is testing a new mechanical heart pump called the Corheart 6 in 50 people with end-stage heart failure. The pump is implanted to help the heart circulate blood. Researchers are checking if the device works safely and effectively at 3 months and 2 years after implantation, focusing on survival without major stroke or device problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Corheart 6 Left Ventricular Assist Device (a mechanical heart pump)
What this could lead to
If successful, this device could offer a reliable, long-term option to keep people with severe heart failure alive and active while they wait for a transplant or as a permanent solution.
What could go wrong
This is an early-stage trial with only 50 participants, so results may not apply to everyone. Risks include stroke, device failure, or infection, and the device requires ongoing medical management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
-
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Hunan, China
-
Fuwai Hospital, Chinese Academy of Medical Sciences(CAMS)
Beijing, Beijing Municipality, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
-
Nanjing First Hospital
Nanjing, Jiangsu, China
-
People's Hospital of Xinjiang Uygur Autonomous Region
Xinjiang, Xinjiang, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
-
The Second XIANGYA Hospital Of Central South University
Changsha, Hunan, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Xijing Hospital of Air Force Medical University
Xi’an, Shanxi, China
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China